blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3694874

EP3694874 - METHODS OF INDUCING COMPLEMENT ACTIVITY [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  07.05.2021
Database last updated on 05.10.2024
FormerRequest for examination was made
Status updated on  17.07.2020
FormerThe international publication has been made
Status updated on  19.04.2019
Formerunknown
Status updated on  23.11.2018
Most recent event   Tooltip13.09.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Bioverativ USA Inc.
951 Gateway Boulevard
South San Francisco, California 94080 / US
[2020/34]
Inventor(s)01 / PANICKER, Sandip
951 Gateway Blvd.
South San Francisco California 94080 / US
02 / MOORE, Stephen
951 Gateway Blvd.
South San Francisco California 94080 / US
03 / NIKITIN, Pavel
951 Gateway Blvd.
South San Francisco California 94080 / US
04 / BYUN, Tony
951 Gateway Blvd.
South San Francisco California 94080 / US
05 / PARRY, Graham
951 Gateway Blvd.
South San Francisco California 94080 / US
 [2020/34]
Representative(s)Zwicker, Jörk
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
[2020/34]
Application number, filing date18801089.611.10.2018
[2020/34]
WO2018US55444
Priority number, dateUS201762570953P11.10.2017         Original published format: US 201762570953 P
US201862637135P01.03.2018         Original published format: US 201862637135 P
[2020/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019075220
Date:18.04.2019
Language:EN
[2019/16]
Type: A1 Application with search report 
No.:EP3694874
Date:19.08.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 18.04.2019 takes the place of the publication of the European patent application.
[2020/34]
Search report(s)International search report - published on:EP18.04.2019
ClassificationIPC:C07K16/18, C07K16/40
[2020/34]
CPC:
C07K16/18 (EP,US); C07K16/40 (EP); A61K2039/505 (EP);
C07K2317/31 (US); C07K2317/565 (US); C07K2317/73 (US);
C07K2317/76 (EP,US); C07K2317/92 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/34]
TitleGerman:VERFAHREN ZUR INDUKTION VON KOMPLEMENTAKTIVITÄT[2020/34]
English:METHODS OF INDUCING COMPLEMENT ACTIVITY[2020/34]
French:PROCÉDÉS PERMETTANT D'INDUIRE UNE ACTIVITÉ DE COMPLÉMENT[2020/34]
Entry into regional phase05.05.2020National basic fee paid 
05.05.2020Designation fee(s) paid 
05.05.2020Examination fee paid 
Examination procedure05.05.2020Amendment by applicant (claims and/or description)
05.05.2020Examination requested  [2020/34]
05.05.2020Date on which the examining division has become responsible
11.05.2021Despatch of a communication from the examining division (Time limit: M04)
21.09.2021Reply to a communication from the examining division
04.09.2023Despatch of a communication from the examining division (Time limit: M02)
10.11.2023Reply to a communication from the examining division
Fees paidRenewal fee
14.10.2020Renewal fee patent year 03
29.09.2021Renewal fee patent year 04
15.09.2022Renewal fee patent year 05
13.09.2023Renewal fee patent year 06
12.09.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]WO2009029669  (NOVELMED THERAPEUTICS INC [US], et al) [X] 1-3,5,6 * examples 1-10; claims 1-74 * [I] 4,7-15;
 [XI]WO2013152020  (NOVELMED THERAPEUTICS INC [US]) [X] 1-3,5,6 * examples 1-7; claims 1-53 * [I] 4,7-15;
 [XP]WO2017176651  (TRUE NORTH THERAPEUTICS INC [US]) [XP] 1-6* claims 1-3 *
by applicantWO9303769
 WO9309239
 WO9319191
 WO9412649
 WO9428938
 WO9500655
 WO9511984
 WO9617951
 WO9712622
 WO9817815
 WO9817816
 WO9818934
 WO9931251
 WO0020561
 US6447784
 WO03042361
 US2004131637
 WO2007004670
 WO2007148971
 US2013195801
 US8734809
    - PULKKINEN; MILLER, J. Bacteriol., (19910000), vol. 173, no. 1, pages 86 - 93
    - ALPUCHE-ARANDA et al., PNAS, (19920000), vol. 89, no. 21, pages 10079 - 83
    - HARBORNE et al., Mol. Micro., (19920000), vol. 6, pages 2805 - 2813
    - DUNSTAN et al., Infect. Immun., (19990000), vol. 67, pages 5133 - 5141
    - MCKELVIE et al., Vaccine, (20040000), vol. 22, pages 3243 - 3255
    - CHATFIELD et al., Biotechnol., (19920000), vol. 10, pages 888 - 892
    - "GenBank", Database accession no. AX798980
    - "GenBank", Database accession no. AX798961
    - "GenBank", Database accession no. AX798183
    - SHETRON-RAMA et al., Infect. Immun., (20020000), vol. 70, pages 1087 - 1096
    - VALDIVIA; FALKOW, Mol. Microbiol., (19960000), vol. 22, page 367
    - HILLEN,W.; WISSMANN, A., Topics in Molecular and Structural Biology, Protein-Nucleic Acid Interaction, Macmillan, (19890000), vol. 10, pages 143 - 162
    - MELTON et al., Nucl. Acids Res., (19840000), vol. 12, page 7035
    - DEBOER et al., Proc. Natl. Acad. Sci. U.S.A., (19830000), vol. 80, pages 21 - 25
    - LI et al., Invest Opthalmol Vis Sci, (19940000), vol. 35, page 2543 2549
    - BORRAS et al., Gene Ther, (19990000), vol. 6, page 515 524
    - LI; DAVIDSON, PNAS, (19950000), vol. 92, page 7700 7704
    - SAKAMOTO et al., H Gene Ther, (19990000), vol. 5, page 1088 1097
    - ALI et al., Hum Gene Ther, (19980000), vol. 9, page 81 86
    - FLANNERY et al., PNAS, (19970000), vol. 94, page 6916 6921
    - BENNETT et al., Invest Opthalmol Vis Sci, (19970000), vol. 38, page 2857 2863
    - JOMARY et al., Gene Ther, (19970000), vol. 4, page 683 690
    - ROLLING et al., Hum Gene Ther, (19990000), vol. 10, page 641 648
    - ALI et al., Hum Mol Genet, (19960000), vol. 5, page 591 594
    - SAMULSKI et al., J. Vir., (19890000), vol. 63, pages 3822 - 3828
    - MENDELSON et al., Virol., (19880000), vol. 166, pages 154 - 165
    - FLOTTE et al., PNAS, (19930000), vol. 90, pages 10613 - 10617
    - MIYOSHI et al., PNAS, (19970000), vol. 94, page 10319 23
    - TAKAHASHI et al., J Virol, (19990000), vol. 73, page 7812 7816
    - MURRY, E. J., Methods in Molecular Biology, Humana Press, Inc., (19910000), vol. 7
    - "GenBank", Database accession no. U89790
    - "GenBank", Database accession no. J01901
    - "GenBank", Database accession no. AF043303
    - "GenBank", Database accession no. AF085716
    - CHLORINI et al., J. Vir., (19970000), vol. 71, pages 6823 - 33
    - SRIVASTAVA et al., J. Vir., (19830000), vol. 45, pages 555 - 64
    - CHLORINI et al., J. Vir., (19990000), vol. 73, pages 1309 - 1319
    - RUTLEDGE et al., J. Vir., (19980000), vol. 72, pages 309 - 319
    - WU et al., J. Vir., (20000000), vol. 74, pages 8635 - 47
    - DALKARA, D et al., Sci Transl. Med., (20130000), vol. 5, no. 189, page 189ra76
    - KOTTERMAN, MA Nat. Rev. Genet., (20140000), vol. 15, no. 7, page 455
    - CARRIER et al., J. Immunol., (19920000), vol. 148, pages 1176 - 1181
    - SIZEMORE et al., Science, (19950000), vol. 270, pages 299 - 302
    - RIDGWAY, A. A. G., "Mammalian Expression Vectors (chapter 24.2)", RIDGWAY, A. A. G., Rodriguez and Denhardt, Vectors, Butterworths, (19880000), pages 470 - 472
 WO1997US15692
 WO2002US33692
 WO2002US33630
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.